Nucelion and Pandorum Partner on ₹17 Crore Eye-Therapy Research Programmes
The Nucelion Pandorum partnership backs two investigational eye programmes with a planned ₹16.97 crore outlay. What it covers and what is undisclosed.
India CAR-T Therapy Development: Nucelion, VeGen Bio Pact
India CAR-T therapy development gets a boost as Nucelion and VeGen Bio partner on VL-2511, an experimental dual-target myeloma therapy.